Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
International Journal of Technology Assessment in Health Care
|
July 22, 2009
Effects of the National Institute for Health and Clinical Excellence's technology appraisals on prescribing and net ingredient costs of drugs in the National Health Service in England
Eva Susanne Dietrich
Pharmazie in Unserer Zeit
|
April 5, 2005
[Cost-benefit aspects of taxane therapy]
Eva Susanne Dietrich
Journal of Medical Economics
|
April 1, 2025
Artificial intelligence in key pricing, reimbursement, and market access (PRMA) processes: better, faster, cheaper-can you really pick two?
Eva Susanne Dietrich
Fertility and Sterility
|
January 12, 2010
Effects of the Statutory Health Insurance Modernization Act on the supply and expenditure situation in cases of assisted reproductive technologies in Germany
Eva Susanne Dietrich, Wenke Wevers
Clinical Pharmacology and Therapeutics
|
January 5, 2026
On Selection and Analytical Transparency in the FRAME Framework for RWE Evaluation
Jörg Tomeczkowski, Eva Susanne Dietrich
German Medical Science : GMS E-Journal
|
August 21, 2010
Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany
Stefan Pscherer, Eva Susanne Dietrich, Franz-Werner Dippel, et al.
Chemotherapy
|
March 20, 2002
Ceftriaxone versus other cephalosporins for perioperative antibiotic prophylaxis: a meta-analysis of 43 randomized controlled trials
Eva Susanne Dietrich, Ute Bieser, Uwe Frank, et al.
BMC Health Services Research
|
May 13, 2023
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?
Michael Drummond, Oriana Ciani, Giulia Fornaro, et al.
Advances in Therapy
|
June 20, 2025
Letter to the Editor Regarding "Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023"
Jörg Tomeczkowski, Friedhelm Leverkus, Paul Bussilliat, et al.
Clinical Pharmacology and Therapeutics
|
May 9, 2024
Questioning Conclusions and Statements on the German HTA System: A Critical Perspective
Jörg Tomeczkowski, Tanja Heidbrede, Friedhelm Leverkus, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
International Journal of Technology Assessment in Health Care
|
July 22, 2009
Effects of the National Institute for Health and Clinical Excellence's technology appraisals on prescribing and net ingredient costs of drugs in the National Health Service in England
Eva Susanne Dietrich
Pharmazie in Unserer Zeit
|
April 5, 2005
[Cost-benefit aspects of taxane therapy]
Eva Susanne Dietrich
Journal of Medical Economics
|
April 1, 2025
Artificial intelligence in key pricing, reimbursement, and market access (PRMA) processes: better, faster, cheaper-can you really pick two?
Eva Susanne Dietrich
Fertility and Sterility
|
January 12, 2010
Effects of the Statutory Health Insurance Modernization Act on the supply and expenditure situation in cases of assisted reproductive technologies in Germany
Eva Susanne Dietrich, Wenke Wevers
Clinical Pharmacology and Therapeutics
|
January 5, 2026
On Selection and Analytical Transparency in the FRAME Framework for RWE Evaluation
Jörg Tomeczkowski, Eva Susanne Dietrich
German Medical Science : GMS E-Journal
|
August 21, 2010
Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany
Stefan Pscherer, Eva Susanne Dietrich, Franz-Werner Dippel, et al.
Chemotherapy
|
March 20, 2002
Ceftriaxone versus other cephalosporins for perioperative antibiotic prophylaxis: a meta-analysis of 43 randomized controlled trials
Eva Susanne Dietrich, Ute Bieser, Uwe Frank, et al.
BMC Health Services Research
|
May 13, 2023
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?
Michael Drummond, Oriana Ciani, Giulia Fornaro, et al.
Advances in Therapy
|
June 20, 2025
Letter to the Editor Regarding "Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023"
Jörg Tomeczkowski, Friedhelm Leverkus, Paul Bussilliat, et al.
Clinical Pharmacology and Therapeutics
|
May 9, 2024
Questioning Conclusions and Statements on the German HTA System: A Critical Perspective
Jörg Tomeczkowski, Tanja Heidbrede, Friedhelm Leverkus, et al.
Page
of 1